Patents by Inventor Vincent M TEDONE

Vincent M TEDONE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition For Treating Tauopathy In The Brain, Brain Stem and Spinal Column
    Publication number: 20220378731
    Abstract: A composition of matter comprising an ?-ketoglutarate (AKG) or an ?-ketoglutaric acid or a salt of an ?-ketoglutarate may be used to treat patients having a neurodegenerative disease, such as amyotrophic lateralsclerosis. The composition may be administered hourly or may be administered once a day depending on the size and activity of the patient and the release coating or mechanism provided. In addition to AKG, a core composition may comprise GABA and a source of coenzyme Q10. Other substances may be provided either orally or intravenous in addition to the core composition, as required to control symptoms, or in order to stimulate stem cells to add motor neurons.
    Type: Application
    Filed: August 9, 2022
    Publication date: December 1, 2022
    Inventor: Vincent M Tedone
  • Composition for treatment of neurodegenerative disease
    Patent number: 11464753
    Abstract: A composition of matter comprising an ?-ketoglutarate (AKG) or an ?-ketoglutaric acid or a salt of an ?-ketoglutarate may be used to treat patients having a neurodegenerative disease, such as amyotrophic lateralsclerosis. The composition may be administered hourly or may be administered once a day depending on the size and activity of the patient and the release coating or mechanism provided. In addition to AKG, a core composition may comprise GABA and a source of coenzyme Q10. Other substances may be provided either orally or intravenous in addition to the core composition, as required to control symptoms, or in order to stimulate stem cells to add motor neurons.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: October 11, 2022
    Assignee: Tedone 3G LLC
    Inventor: Vincent M Tedone
  • COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISEASE
    Publication number: 20190151275
    Abstract: A composition of matter comprising an ?-ketoglutarate (AKG) or an ?-ketoglutaric acid or a salt of an ?-ketoglutarate may be used to treat patients having a neurodegenerative disease, such as amyotrophic lateralsclerosis. The composition may be administered hourly or may be administered once a day depending on the size and activity of the patient and the release coating or mechanism provided. In addition to AKG, a core composition may comprise GABA and a source of coenzyme Q10. Other substances may be provided either orally or intravenous in addition to the core composition, as required to control symptoms, or in order to stimulate stem cells to add motor neurons.
    Type: Application
    Filed: January 18, 2019
    Publication date: May 23, 2019
    Inventor: Vincent M Tedone
  • COMPOSITION FOR TREATMENT OF NEURODEGENERATIVE DISEASE
    Publication number: 20150328176
    Abstract: A composition of matter comprising an ?-ketoglutarate (AKG) or an ?-ketoglutaric acid or a salt of an ?-ketoglutarate may be used to treat patients having a neurodegenerative disease, such as amyotrophic lateral sclerosis. The composition may be administered hourly or may be administered once a day depending on the size and activity of the patient and the release coating or mechanism provided. In addition to AKG, a core composition may comprise GABA and a source of coenzyme Q10. Other substances may be provided either orally or intravenous in addition to the core composition, as required to control symptoms, or in order to stimulate stem cells to add motor neurons.
    Type: Application
    Filed: January 24, 2014
    Publication date: November 19, 2015
    Applicant: Winning the Fight Inc.
    Inventor: Vincent M TEDONE